NewslettersHuman Immunology NewsClinical Trials of Self-Replicating RNA-Based Cancer VaccinesBy Laurisa Dohm - February 14, 20230178Scientists review the clinical experience with self-replicating RNA-based cancer vaccines, and recent safety data from a study combining a viral replicon particles encoding HER2 plus an anti-PD1 monoclonal antibody.[Cancer Gene Therapy]Full Article